Skip to main content
Caplight Logo









ImageCyte Technologies

ImageCyte Technologies

Private
VancouverHealthcare & Life Scienceshttps://www.imagecyte.bio/

Last Round

Grant

Oct 1, 2025

Total Funding Raised

$10,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ImageCyte Technologies is a life science company that develops and manufactures high-density nanowell imaging plates to enhance single-cell imaging and biological research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

microplatessingle-cell imaging3d cell culturelab consumablesnanowell platescell analysisdrug discovery toolsbiotech hardwarecell-based assayssingle-cell isolationlabwarehigh-throughput screeninglife science research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ImageCyte Technologies Comparables

Compare ImageCyte Technologies with similar companies based on industry and business-model similarity.

ImageCyte Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ibidi GmbH
77%
Cellvis
76%
SIRION Biotech
75%

ImageCyte Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 1, 2025
Early FundingAug 27, 2025
AcceleratorJan 24, 2025
AcceleratorOct 8, 2024

Key People

Founding team and executive leadership

Sam Berryman

Chief Executive Officer

Executive Team

ImageCyte Technologies Investors

Notable investors and investment history

ImageCyte Technologies investors
InvestorRounds
Life Sciences BCAccelerator
Innovate BCGrant
HATCH Venture BuilderAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 15, 2025

    Grew 300% QoQ from 1 to 4 employees.

  • Oct 1, 2025

    $10K grant received from Innovate BC.

ImageCyte Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ImageCyte Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ImageCyte Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver
Employee Range4
Year Founded2023
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?